Striving for better access to care

The Novo Nordisk Haemophilia Foundation (NNHF) is a grant-making, non-profit organisation established in 2005 in Zurich, Switzerland.

NNHF is dedicated to improving access to quality care for people with haemophilia and rare bleeding disorders in developing and emerging countries.

Around 80% of people with haemophilia live in the developing world, where many people are still undiagnosed, and few receive adequate care. NNHF is driven by its vision that all people with haemophilia and rare bleeding disorders receive care and treatment, wherever they live.

Impacting care. Together

Our Vision

All people with haemophilia or rare bleeding disorders receive care and treatment, wherever they live.

Our Approach

Together with partners in the countries and international experts, NNHF develops and implements programmes which create real impact for people with haemophilia and rare bleeding disorders.

Our Team

The NNHF Management team is responsible for NNHF’s operations. The team ensures the organisation receives suitable programme applications and adopts a results-oriented approach to programme management, allocation of funds and budget controls.

Our origins

The Novo Nordisk Haemophilia Foundation (NNHF) was founded in 2005 by Novo Nordisk, a global Danish pharmaceutical company. NNHF reflects Novo Nordisk’s commitment to corporate social responsibility.

Realising the vast disparity between standards of care around the world, NNHF was set up to improve care for people with haemophilia and allied bleeding disorders in developing and emerging countries.

Based in Zurich, Switzerland, NNHF receives approximately CHF 2.8 million per year from its main benefactor, Novo Nordisk. Other donors are permitted by the foundation’s Council.

How is NNHF structured
and governed?

NNHF is a non-profit organisation. As a grant-making foundation, NNHF is an associated partner of SwissFoundations and aligns its governance standards with the principles and recommendations of the Swiss Foundation Code.

NNHF Uzbek Samarkand

NNHF Council

NNHF is governed by the Foundation Council. The Council comprises globally renowned experts in the field of haemophilia and allied bleeding disorders, alongside members from Novo Nordisk.

NNHF Council members exercise their duty without remuneration except for the reimbursement of their expenses.

Operationally managed by the NNHF team

The NNHF Management Team includes six employees, who are responsible for the daily management of NNHF and its development, following clearly defined operating principles and processes.

NNHF’s annual financial statements are audited by PricewaterhouseCoopers AG. The Swiss authorities ensure that the proceeds of NNHF are spent in accordance with its objectives and inspect proper financial and liquidity planning along with financial reporting.

Our Council – rules and responsibilities

The Foundation Council governs NNHF, ensuring its goals, activities and structures are as transparent as possible. As the supervisory and main decision-making body of NNHF, the Council makes decisions regarding submitted programmes and NNHF’s strategic direction. It also approves the annual budget and ensures proper allocation of funds.

The Foundation Council convenes twice a year.The NNHF Council entrusts daily management to NNHF Management Team.

Explore our programmes

NNHF funds sustainable programmes that ensure better care for people with haemophilia living in developing and emerging countries by building capacity, improving diagnosis rates, increasing access to care, and helping give a voice to all people with haemophilia.

explore programmes